Type 1 and type 2 diabetes both cause high blood sugar, but they arise from fundamentally different problems in the body. Type 1 is an autoimmune disease where the immune system destroys the cells that make insulin. Type 2 is a metabolic condition where the body still produces insulin but can’t use it effectively. That core distinction drives nearly every difference between the two, from who gets them to how they’re treated.
What Happens in the Body
In type 1 diabetes, the immune system mistakenly attacks and kills the insulin-producing beta cells in the pancreas. Over time, the pancreas loses its ability to make insulin almost entirely. Without insulin, your cells can’t absorb glucose from the bloodstream, so blood sugar rises while your cells essentially starve for energy.
Type 2 diabetes starts differently. Your cells gradually become resistant to insulin, meaning they stop responding to it properly. The pancreas compensates by pumping out more insulin, but eventually it can’t keep up. The result is the same, high blood sugar, but the underlying cause is resistance rather than destruction. Over many years, the pancreas can wear out from overproduction, and some people with type 2 do eventually lose significant insulin production as well.
Interestingly, the two types can start to resemble each other over time. People with long-standing type 2 diabetes may develop beta cell failure, while people with type 1 can develop insulin resistance as their condition progresses.
Who Gets Each Type
Type 2 diabetes is far more common. Of the roughly 40 million people in the United States living with diabetes, about 2.1 million have type 1. That means type 2 accounts for roughly 90 to 95 percent of all cases. Globally, type 2 affects about 8.5% of the adult population, while type 1 affects around 1% of people in developed countries.
Type 1 is most often diagnosed in children, teenagers, and young adults, though it can appear at any age. A related condition called latent autoimmune diabetes in adults (LADA) is essentially a slower-developing form of autoimmune diabetes that shows up after age 30, with a median diagnosis age of 42. People with LADA are often initially misdiagnosed with type 2 because of their age.
Type 2 diabetes typically develops in adults over 40, though rising obesity rates have pushed diagnoses into younger age groups, including adolescents. Being overweight, physically inactive, and having a family history of the disease all significantly raise risk. Genetics play a role in both types, but in different ways. A Finnish twin study found that when one identical twin has type 2 diabetes, the other develops it about 34% of the time. For type 1, that concordance rate is 23%. Both types have a genetic component, but type 2 appears to be more strongly influenced by a combination of genes and environment, particularly lifestyle factors like diet and activity level.
How Symptoms Appear
Both types share the classic symptoms of high blood sugar: increased thirst, frequent urination, fatigue, and blurred vision. The difference is in timing.
Type 1 symptoms can appear suddenly, over just a few weeks or months, and they tend to be severe. Rapid, unexplained weight loss is a hallmark because the body, unable to use glucose, starts breaking down fat and muscle for energy. Type 2 symptoms develop over years. Many people have no noticeable symptoms at all and only discover the condition through routine blood work. By the time type 2 is diagnosed, it may have been silently causing damage for a long time.
How Doctors Tell Them Apart
Standard blood sugar tests (fasting glucose and HbA1c) can diagnose diabetes but don’t reliably distinguish between the two types. When the type is unclear, doctors use two additional tools.
The first is autoantibody testing. People with type 1 diabetes carry specific antibodies that target their own pancreatic cells. Finding these antibodies in the blood confirms an autoimmune process is at work. The second is C-peptide testing, which measures how much insulin the pancreas is still producing. A C-peptide level below 0.2 nmol/L strongly suggests type 1 diabetes, indicating the pancreas has lost most of its insulin-making capacity. In one large study, 48% of people within five years of a type 1 diagnosis still had some measurable beta cell function, but that number dropped to just 8% among those who’d had the disease for five to fifteen years.
Treatment Differences
People with type 1 diabetes need insulin from the day of diagnosis. There is no alternative. Because their pancreas produces little to no insulin, they rely on injections or an insulin pump to survive. Managing type 1 involves carefully matching insulin doses to food intake and activity levels, typically requiring multiple daily decisions about dosing.
Type 2 diabetes treatment usually starts with lifestyle changes and oral medications. The most common first-line medication works by reducing the amount of glucose the liver releases and helping the body use insulin more efficiently. If that’s not enough, doctors can add other classes of oral medications that work through different mechanisms: some help the kidneys remove excess glucose, others boost the body’s own insulin-stimulating hormones, and some directly increase insulin release from the pancreas. Injectable medications that mimic gut hormones are another option. Some people with type 2 do eventually need insulin, particularly as beta cell function declines over the years, but many manage the condition without it.
Can Either Type Go Into Remission?
Type 2 diabetes can go into remission. An international consensus group defined remission as maintaining an HbA1c below 6.5% for at least three months without taking any blood sugar-lowering medication. This can happen through significant weight loss, dietary changes, or bariatric surgery. Remission doesn’t mean the disease is cured. The underlying tendency toward insulin resistance remains, and blood sugar levels need ongoing monitoring because the condition frequently returns.
Type 1 diabetes does not have a recognized remission pathway. Because the immune system has destroyed the insulin-producing cells, no lifestyle intervention or currently available treatment can restore that lost function. Some people experience a brief “honeymoon period” shortly after diagnosis when the remaining beta cells rally and insulin needs temporarily drop, but this fades as the immune attack continues.
Acute Complications
Each type carries a characteristic emergency that reflects its underlying biology. Type 1 diabetes is more closely associated with diabetic ketoacidosis (DKA), a condition where the near-total absence of insulin forces the body to break down fat rapidly. This floods the blood with acidic byproducts called ketones, causing nausea, abdominal pain, a distinctive fruity breath, and rapid breathing. Left untreated, DKA is life-threatening.
Type 2 diabetes is more prone to a different emergency called hyperosmolar hyperglycemic state, where blood sugar climbs to extreme levels, often above 600 mg/dL, causing severe dehydration. Because people with type 2 still produce some insulin, their bodies don’t typically shift into heavy ketone production. Instead, the danger comes from the sheer concentration of glucose in the blood drawing water out of tissues. This condition develops more slowly than DKA but carries a higher mortality rate, partly because it tends to affect older adults who may have other health conditions.
Long-Term Outlook
Both types of diabetes increase the risk of the same long-term complications: heart disease, kidney damage, nerve damage, and vision loss. Consistently elevated blood sugar damages blood vessels throughout the body regardless of the underlying cause. The key factor in preventing complications for either type is keeping blood sugar levels as close to normal as possible over time.
The practical daily experience differs significantly, though. Type 1 requires constant vigilance around insulin dosing, carbohydrate counting, and blood sugar monitoring. Type 2 often centers more on sustained lifestyle changes, weight management, and medication adherence. Both are lifelong conditions, but the tools and daily routines for managing each one look quite different.